Mechanism of intranasal drug delivery directly to the brain

  title={Mechanism of intranasal drug delivery directly to the brain},
  author={Tyler P Crowe and Heather West Greenlee and Anumantha G. Kanthasamy and Walter H Hsu},
  journal={Life Sciences},

Figures from this paper

Brain Targeting Through Intranasal Route: An Overview

This review highlighted the challenges, approaches for brain targeting and various drug delivery systems developed with different drugs targeting to brain through nasal administration.

Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

Important neurological disorders, challenges in drug delivery to the disordered CNS, and new nasal delivery techniques designed to overcome these challenges and facilitate more efficient and targeted drug delivery are described.


This review aims to identify the new advances in the nasal administration of brain-based DDSs for Migraines via the intranasal route, as effective means of concentrating the brain without toxicity.

Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases

This review provides an overview of the nose-to-brain route and discusses the recent advances made on the design of intranasal drug delivery systems of central nervous system therapeutics to the brain, focusing in particular on stimuli-responsive hydrogels.

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin

The CNS drug delivery approach into the brain using nanodelivery strategies for insulin through transcellular routes based on receptor-mediated transcytosis or through paracellular routes basedon escaping the tight junction at the olfactory epithelium is introduced.

Drug delivery and targeting to the brain through nasal route: Mechanisms, Applications and Challenges.

This review tries to address the recent developments in the area of direct drug delivery to the brain through nasal route through the use of nanotechnological approaches.

Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders

The present review highlights research scenarios of nanoemulsions for nose-to-brain delivery for the management of CNS ailments classified on the basis of brain disorders and further identifies the areas that remain unexplored.

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects

Recent advances in nanocarrier-based nasal drug delivery systems for the direct and effective brain delivery of the neurotherapeutic molecules are elaborates on.



Intranasal drug delivery for brain targeting.

This review will discuss some pertinent issues to be considered and challenges to brain targeted intranasal drug delivery and a few marketed and investigational drug formulations will also be discussed.

The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS

This study demonstrates that surgical transection, and the resulting structural disruption of the RMS, in mice effectively obstructs the uptake of intranasally administered radioligands into the CNS, and demonstrates that intranAsal administration in mice allows agents to be distributed throughout the entire brain.

Intranasal delivery of biologics to the central nervous system.

Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain

The ability to transiently and safely increase drug delivery from the nose to the brain represents a non-invasive way to improve treatment of patients with brain disorders.

Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin

It is concluded that albumin, a protein that can act as a drug carrier but is excluded from brain by the blood-brain barrier, reaches all parts of the brain through a dose-dependent mechanism that may involve fluid-phase transcytosis and, as illustrated by leptin, can affect the delivery of other substances to the brain after their i.n. administration.

The blood-brain barrier: Bottleneck in brain drug development

This work has shown that the blood-brain barrier provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences.

Rapid Transport within Cerebral Perivascular Spaces Underlies Widespread Tracer Distribution in the Brain after Intranasal Administration

C cerebral perivascular convection likely has a key role in intranasal drug delivery to the brain, as shown by ex vivo fluorescence imaging results.

Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.

Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.

Results show intranasal delivery to be an effective way to deliver insulin to the brain and reversed learning and memory deficits in an AD mouse model.

Subarachnoid space of the CNS, nasal mucosa, and lymphatic system.

There is a body of evidence indicating that tracers placed in the CSF will quickly move via the olfactory nerve to the nasal mucosa and then to the cervical lymph nodes, and some of the movement of tracers may occur within the Olfactory perineural space.